Impact News +++ NRG Energy Q1 Earnings Decline, Reaffirms FY26 Outlook (AFX) +++ NRG ENERGY Aktie +4,00%

LIFECORE Aktie

>LIFECORE Aktienkurs

4.16 EUR (TradegateBSX)

Ask: 4.26 EUR / 1000 Stück

Bid: 4.06 EUR / 936 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

LIFECORE Aktie über LYNX handeln

Intraday

1 Jahr

>LIFECORE Performance

1 Woche: +0,7%

1 Monat: +32,5%

3 Monate: -31,5%

6 Monate: -25,1%

1 Jahr: -28,7%

laufendes Jahr: -37,1%

>LIFECORE Aktie

Name:

LIFECORE BIOMEDICAL

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US5147661046 / 899376

Symbol/ Ticker:

LDE (Frankfurt) / LFCR (NASDAQ)

Kürzel:

FRA:LDE, ETR:LDE, LDE:GR, NASDAQ:LFCR

Index:

Webseite:

https://www.lifecore.com/

Profil:

Lifecore Biomedical Inc. is a prominent entity in the biotechnology sector, primarily engaged in the manufacture and development of high-quality biomedical products. The company specializes in the production of hyaluronan and other polysaccharide-bas..
>Volltext..

Marktkapitalisierung:

168.19 Mio. EUR

Unternehmenswert:

317.25 Mio. EUR

Umsatz:

EBITDA:

Nettogewinn:

Gewinn je Aktie:

Schulden:

122.78 Mio. EUR

Liquide Mittel:

14.9 Mio. EUR

Operativer Cashflow:

Bargeldquote:

0.74

Umsatzwachstum:

Gewinnwachstum:

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

LIFECORE

Letzte Datenerhebung:

06.05.26

>LIFECORE Kennzahlen

Aktien/ Unternehmen:

Aktien: 37.48 Mio. St.

Frei handelbar: 91.18%

Leerverk. Aktien: 7.08%

Rückkaufquote: -

Mitarbeiter: 406

Umsatz/Mitarb.: 0.27 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 26.74%

Bewertung:

KGV: -

KGV lG: -

KUV: -

KBV: -

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -

Operative Marge: -

Managementeffizenz:

Gesamtkaprendite: -

Eigenkaprendite: -

>LIFECORE Peer Group

Gesundheit, Augenmedizin, Medizinprodukte & -technik/ Implantate/ Wundpflege

>LIFECORE Chart & Kurs - NASDAQ

>LIFECORE News

06.05.26 - 13:21	Lifecore Biomedical GAAP EPS of $0.43 beats by $0.72, revenue of $23.2M misses by $2.76M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

06.05.26 - 13:09	Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update (GlobeNewswire EN)
	Lifecore's Q1 2026 Earnings...

22.04.26 - 22:09	Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
	Lifecore announces inducement grant...

08.04.26 - 14:03	Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit (GlobeNewswire EN)
	Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit...

26.03.26 - 21:09	Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)
	Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)...

26.03.26 - 12:03	Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer (GlobeNewswire EN)
	Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer...

23.03.26 - 12:03	Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company (GlobeNewswire EN)
	Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company...

17.03.26 - 16:18	Lifecore Biomedical stellt strategische Neuausrichtung und Wachstumsziele vor (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

17.03.26 - 14:03	Lifecore Stock Sinks As Delayed Launches Push Growth Further Out (Benzinga)
	Lifecore stock plunges after earnings miss and weak 2026 outlook, with customer losses and delayed growth plans weighing on shares. Importance Rank: 1 read more...

16.03.26 - 21:57	Lifecore targets 12% revenue CAGR through 2029 as midterm pipeline milestones shift (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

16.03.26 - 13:12	Lifecore Biomedical GAAP EPS of -$0.16, revenue of $35.75M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

10.03.26 - 21:09	Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum (GlobeNewswire EN)
	Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum...

09.03.26 - 21:09	Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026 (GlobeNewswire EN)
	Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026...

04.03.26 - 22:06	Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment (GlobeNewswire EN)
	Lifecore Biomedical and Indomo sign new agreement to support innovative drug/device combination acne treatment....

17.02.26 - 13:09	Lifecore Biomedical to Participate at DCAT Week 2026 (GlobeNewswire EN)
	CHASKA, Minn., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate at DCAT Week 2026. The conference will take place March 23-26, 2026, in New York City....

29.01.26 - 23:12	HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire)
	Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Lifecore Biomedical, Inc. (NASDAQ: LFCR)......

16.01.26 - 22:48

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire EN)

CHASKA, Minn., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on January 14, 2026, the Lifecore compensation committee approved grants under Lifecore's Equity Inducement Plan, as amended (the “Inducement Plan”) of restricted stock unit (“RSU”) awards with respect to an aggregate 1,738 shares of its common stock and stock options for an aggregate 8,775 shares of common stock to two newly hired employees of Lifecore. The RSU award and stock options were granted on January 14, 2026, pursuant to the offer letters between Lifecore and each employee, and as a material inducement to each employee joining Lifecore....

13.01.26 - 19:54	Grabar Law Office: Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Settles (Newsfile)
	Philadelphia, Pennsylvania--(Newsfile Corp. - January 13, 2026) - Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR) as a securities fr......

08.01.26 - 23:00	Grabar Law Office: Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement (Newsfile)
	Philadelphia, Pennsylvania--(Newsfile Corp. - January 8, 2026) - Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR) The investigation c......

30.12.25 - 22:06	Grabar Law Office: Notice to Long-Term Shareholders of Lifecore Biomedical, Inc. (LFCR): Grabar Law Office Investigates Claims on Your Behalf as Securities Fraud Class Action Reaches Settlement (Newsfile)
	Philadelphia, Pennsylvania--(Newsfile Corp. - December 30, 2025) - Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR) The investigation......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Das sind halt die Freuden eines Preisministers, wenn ab und zu nicht alles teurer wird. - Dr. Josef Staribacher

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram